18th of June 2026; Mountain View, California, USA
Cellestial Health, an innovative pharmaceutical development company offering a paradigm shift approach to Parkinson’s treatments, announces its selection and participation at the 2025 Venture Summit West, which took place June 16–17, 2025 at the Computer History Museun in Mountain View, Silicon Valley. Hosted by youngStartup Ventures, the summit is recognized as one of the premier forums in the USA and beyond where bold ideas meet the capital and connections needed to fuel tomorrow’s breakthroughs.
The Venture Summit West selected 200 Top Innovators across sectors that are redefining the way we live, work, and thrive. Handpicked by the youngStartup Ventures selection committee, these presenting companies showcase the cutting edge of innovation—from life-changing biotech and AI-driven platforms to transformative clean energy and frontier technologies.
By earning a coveted spot on this stage, Cellestial Health put a spotlight on unmet medical needs in Parkinson’s disease and opportunities for disease modification by tapping into the astrocyte biology to a powerhouse audience of venture capitalists, corporate investors, angel networks, and industry visionaries eager to discover the next category-defining companies.
“Wherever we go in the world, there is a sense of appreciation that Parkinson’s is a growing problem, and that fundamentally new treatment approaches are needed,” said Dr Nat Hastings, CEO.
“Our approach at Cellestial is differentiated in a meaningful and scientifically-supported way. Astrocyte-protective therapies are presently overlooked but the field is growing rapidly; it is an attractive point for investors to support an emerging area with a broad potential in brain health.”
Further, Dr Nat Hastings paid a visit to the UK Department of Business and Trade in San Francisco to strengthen the company’s ties with the support system in the USA for UK-based businesses, and to research colleagues at Stanford University.
About Venture Summit:
Hosted by youngStartup Ventures, Venture Summit West convenes the brightest entrepreneurs, investors, and thought leaders driving innovation forward. Over two dynamic days, attendees explore the trends, technologies, and partnerships defining the future economy.
For more information on the New York Venture Summit, visit: https://youngstartup.com/upcoming
About Cellestial Health:
We know that the whole brain suffers in disease – yet only one half of it is protected by approved drugs. Cellestial Health is a pharmaceutical spin-out from the University of Cambridge developing small molecule drugs that protect an overlooked half of the brain – networks of brain cells called astrocytes, to stop progression of Parkinson’s and other neurological conditions.
Media Contact: media@cellestialhealth.com